Home / ANKH Knockout Cell Lines

ANKH Knockout Cell Lines

Gene: ANKH

Official Full Name: ANKH inorganic pyrophosphate transport regulatorprovided by HGNC

Gene Summary: This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00077 ANKH Knockout cell line (293T) Human ANKH 1:3~1:6 Negative Online Inquiry
KO06897 ANKH Knockout cell line (HeLa) Human ANKH 1:3~1:6 Negative Online Inquiry
KO06898 ANKH Knockout cell line (HCT 116) Human ANKH 1:2~1:4 Negative Online Inquiry
KO06899 ANKH Knockout cell line (HEK293) Human ANKH 1:3~1:6 Negative Online Inquiry
KO06900 ANKH Knockout cell line (A549) Human ANKH 1:3~1:4 Negative Online Inquiry

Background

ANKH Gene Knockout Cell Lines are highly specialized cellular models designed to facilitate the study of the ANKH gene, which encodes a protein crucial for inorganic pyrophosphate transport and is implicated in various bone and mineral disorders. These knockout cell lines are meticulously engineered using CRISPR-Cas9 gene-editing technology to create definitive models devoid of the ANKH gene, allowing researchers to analyze the functional consequences of its absence and the molecular pathways it influences.

The key function of ANKH Gene Knockout Cell Lines lies in their ability to elucidate the role of the ANKH protein in physiological and pathological conditions. By enabling the precise observation of changes in cellular behavior, metabolism, and signaling pathways, these cell lines contribute invaluable insights into disorders such as osteoarthritis and generalized arterial calcification of infancy. The mechanistic understanding gained from these studies has significant implications for the development of novel therapeutic strategies targeting mineralization diseases.

From a scientific standpoint, the applications of ANKH Gene Knockout Cell Lines extend into both foundational research and clinical scenarios. Their use is paramount in drug discovery initiatives, where determining the effects of pharmacological agents on mineral metabolism can lead to targeted treatment options. The unique ability to create a controlled genetic background further enhances their application in high-throughput screening initiatives.

Compared to alternatives such as traditional transgenic models, ANKH Gene Knockout Cell Lines offer several distinct advantages. They present lower variability, shorter lead times for experimentation, and greater scalability for various assays. Moreover, these cell lines are readily translatable into in vivo models, facilitating seamless downstream research applications.

Researchers and clinicians looking for reliable models that yield consistent, reproducible results will find ANKH Gene Knockout Cell Lines an essential asset in their laboratories. The scientific community will benefit from this innovative tool, expediting research aimed at enhancing our understanding of mineral metabolism and its related pathologies.

Our company prides itself on its extensive expertise in developing state-of-the-art biological products that empower researchers. With a commitment to advancing scientific discovery, we continue to offer tools that meet the evolving needs of the modern research landscape.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.